Garantie de satisfaction à 100% Disponible immédiatement après paiement En ligne et en PDF Tu n'es attaché à rien
Recherché précédemment par vous
Summary Wk4Assgn.E6630.docx NRNP 6630 Week Four: Pediatric and Mood Disorders College of Nursing-PMHNP, Walden University NRNP 6630: Psychopathology and Diagnostic Reasoning Introduction Depression in a clinical aspect is defined as a medical and psychi€6,90
Ajouter au panier
Summary Wk4Assgn.E6630.docx NRNP 6630 Week Four: Pediatric and Mood Disorders College of Nursing-PMHNP, Walden University NRNP 6630: Psychopathology and Diagnostic Reasoning Introduction Depression in a clinical aspect is defined as a medical and psychi
3 vues 0 achat
Cours
Purdue
Établissement
Purdue University
Wk4Assgn.E NRNP 6630 Week Four: Pediatric and Mood Disorders College of Nursing-PMHNP, Walden University NRNP 6630: Psychopathology and Diagnostic Reasoning Introduction Depression in a clinical aspect is defined as a medical and psychiatric illness that causes severe symptoms, including ...
wk4assgne6630docx nrnp 6630 week four pediatric and mood disorders college of nursing pmhnp
walden university nrnp 6630 psychopathology and diagnostic reasoning introduction depression i
École, étude et sujet
Purdue University
Purdue
Tous les documents sur ce sujet (704)
Vendeur
S'abonner
helperatsof1
Avis reçus
Aperçu du contenu
NRNP 6630
Week Four: Pediatric and Mood Disorders
College of Nursing-PMHNP, Walden University
NRNP 6630: Psychopathology and Diagnostic Reasoning
Introduction
Depression in a clinical aspect is defined as a medical and psychiatric illness that causes
severe symptoms, including tiredness, low mood, lack of pleasure, and loss of interest, which
can, in some cases, result in suicidal thoughts. According to SAMHSA, the national incidence
of African American children aged 5 to 11 who are experiencing depression correlates with the
increase in suicide rates seen nationally. In the general population, suicide was ranked as the
10th leading cause of death by people in their age group. Researchers say that children are
susceptible to long-term illnesses such as physical or sexual violence, negligence, the effects of
loss,
bullying, or social stigmatization, as well as well as social tension, predispose them to
developing disorders. The study aims to investigate three solutions for an 8-year-old African
American boy suffering from depression and who displays all the signs and symptoms of the
disease, It would also serve as a measure of how ethically sensitive it is to handle this client, the
client must meet at least five of the criteria stipulated in the most recent edition of the
Diagnostic and Statistical Manual of Mental Disorders (DSM-5), It is highly important for
PMHPs to use extreme caution when administering psychotropic medications directly to
pediatric patients. This paper would identify the care strategy for treating the eight-year-dosing
, patient, which involves three treatment choices, and clarify the reasoning and assessment of
each treatment approach.
Decision #1
Zoloft is taken orally once a day, while Paxil and Wellbutrin are both given orally twice
a day. The first line of childhood and teen antidepressants was SSRIs (SSRIs for the younger age
groups) (Dwyer and Bloch, 2019). This removes Wellbutrin from consideration from this option.
The drug's manufacturer has not yet been able to do enough clinical trials in pediatrics to
recommend it as a first-line therapy and Furthermore, the medication is also associated with risk
of weight loss and epilepsy (Dwyer and Bloch, 2019). It was announced that Paxil could raise
the risk of suicidal thoughts or suicidal behavior in those under the age of eighteen (Hect and
Hect,
2003). There are no clinical trials proving that show that Paxil is successful in treating
children with MDD (Hect and Hect, 2003). Studies also shown a 3.4% higher suicide rates in
children who were prescribed paroxetine (compared to 1% who were not) (8 out of 647; 1.2
percent). There was no instance of suicide among the patients in the data in these studies.
(Waechter,
2003). Thus, in order to treat the client, I agreed to give him Zoloft 25 mg daily. My target of
Zoloft 25 mg a day is to reduce depressive symptoms with few or no side effects. In the coming
weeks, we will see if there are any side effects. In terms of depressive symptoms, the client
reported having returned to the clinic after four weeks, no improvement was seen. therapeutic
reaction doesn't often appear with a reduced dosage of the drug Sometimes the dosage will
need to be increased before a clinical reaction is shown. Each patient responds differently to
medications. Patient education is important enough that the patient doesn't feel they are the
subject of urgent attention. There have been no side effects in the client's life from the use of
Les avantages d'acheter des résumés chez Stuvia:
Qualité garantie par les avis des clients
Les clients de Stuvia ont évalués plus de 700 000 résumés. C'est comme ça que vous savez que vous achetez les meilleurs documents.
L’achat facile et rapide
Vous pouvez payer rapidement avec iDeal, carte de crédit ou Stuvia-crédit pour les résumés. Il n'y a pas d'adhésion nécessaire.
Focus sur l’essentiel
Vos camarades écrivent eux-mêmes les notes d’étude, c’est pourquoi les documents sont toujours fiables et à jour. Cela garantit que vous arrivez rapidement au coeur du matériel.
Foire aux questions
Qu'est-ce que j'obtiens en achetant ce document ?
Vous obtenez un PDF, disponible immédiatement après votre achat. Le document acheté est accessible à tout moment, n'importe où et indéfiniment via votre profil.
Garantie de remboursement : comment ça marche ?
Notre garantie de satisfaction garantit que vous trouverez toujours un document d'étude qui vous convient. Vous remplissez un formulaire et notre équipe du service client s'occupe du reste.
Auprès de qui est-ce que j'achète ce résumé ?
Stuvia est une place de marché. Alors, vous n'achetez donc pas ce document chez nous, mais auprès du vendeur helperatsof1. Stuvia facilite les paiements au vendeur.
Est-ce que j'aurai un abonnement?
Non, vous n'achetez ce résumé que pour €6,90. Vous n'êtes lié à rien après votre achat.
